Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
indiana blog main
11
×
national blog main
11
×
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
venture capital
11
×
biotech
boulder/denver blog main
detroit blog main
life sciences
national top stories
texas blog main
wisconsin blog main
boston top stories
national
texas top stories
boulder/denver top stories
detroit top stories
indiana top stories
new york top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
wisconsin top stories
vc
cancer
fda
startups
ipo
novartis
biogen
celgene
clinical trials
deals
gene editing
medical devices
What
bio
roundup
developing
ipo
new
patients
covid
fda
investors
life
medicines
million
science
talk
years
abbvie’s
acquisitions
activity
advantages
ahead
allogene
announced
approvals
asco
bar
barbecuing
becker
beta
better
billions
biogen
bionics
biopharma
blood
boston’s
branded
brings
business
camping
cancer
Language
unset
Current search:
" national blog main "
×
" venture capital "
×
" indiana blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect